Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose A cross-sectional survey was conducted to explore the current awareness and use of complementary and alternative medicine (CAM), as well as attitudes toward CAM, in patients with cancer and their family members in South Korea. Materials and Methods Between September 21 and October 31, 2017, a 25-item questionnaire regarding CAM experiences among cancer patients and their family members was conducted in 10 oncology clinics in South Korea after institutional review board approval at each institution. Results In total, 283/310 patients were analyzed. The median age was 60 years, and 60% were male. Most of the patients were actively receiving anticancer treatment at the time of the survey. A total of 106 patients (37%) had experienced a median of two types (interquartile range, 1 to 3) of CAM. Belief in CAM (odds ratio [OR], 3.015; 95% confidence interval [CI], 1.611 to 5.640) and duration of disease (OR, 1.012; 95% CI, 1.004 to 1.020) were independent factors for using CAM in multivariable analysis. Belief in CAM was significantly associated with current use of CAM (OR, 3.633; 95% CI, 1.567 to 8.424). Lay referral was the most common reason for deciding to use CAM, and only 25% of patients (72/283) discussed CAM with their physicians. Conclusion Patient attitudes toward and confidence in CAM modalities were strongly associated with their CAM experiences, and only a small number of patients had an open discussion about CAM with their physicians. A patient education program for CAM is needed.
Abstract
Purpose A cross-sectional survey was conducted to explore the current awareness and use of complementary and alternative medicine (CAM), as well as attitudes toward CAM, in patients with cancer and their family members in South Korea. Materials and Methods Between September 21 and October 31, 2017, a 25-item questionnaire regarding CAM experiences among cancer patients and their family members was conducted in 10 oncology clinics in South Korea after institutional review board approval at each institution. Results In total, 283/310 patients were analyzed. The median age was 60 years, and 60% were male. Most of the patients were actively receiving anticancer treatment at the time of the survey. A total of 106 patients (37%) had experienced a median of two types (interquartile range, 1 to 3) of CAM. Belief in CAM (odds ratio [OR], 3.015; 95% confidence interval [CI], 1.611 to 5.640) and duration of disease (OR, 1.012; 95% CI, 1.004 to 1.020) were independent factors for using CAM in multivariable analysis. Belief in CAM was significantly associated with current use of CAM (OR, 3.633; 95% CI, 1.567 to 8.424). Lay referral was the most common reason for deciding to use CAM, and only 25% of patients (72/283) discussed CAM with their physicians. Conclusion Patient attitudes toward and confidence in CAM modalities were strongly associated with their CAM experiences, and only a small number of patients had an open discussion about CAM with their physicians. A patient education program for CAM is needed.
참고문헌 (29)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
- Rashrash M, "Prevalence and predictors of herbal medicine use among adults in the United States", J Patient Exp, 4, pp.108~113 (2017)
- Buckner CA, "Complementary and alternative medicine use in patients before and after a cancer diagnosis", Curr Oncol, 25, pp.e275~e281 (2018)
- Berretta M, "Use of complementary and alternative medicine(CAM)in cancer patients : an Italian multicenter survey", Oncotarget, 8, pp.24401~24414 (2017)
- Choi JY, "Complementary and alternative medicine use among cancer patients at the end of life : Korean national study", Asian Pac J Cancer Prev, 13, pp.1419~1424 (2012)
- Scott JA, "Use of complementary and alternative medicine in patients with cancer : a UK survey", Eur J Oncol Nurs, 9, pp.131~137 (2005)
- Hlubocky FJ, "Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials : a study of prognosis, quality of life, and preferences for decision making", J Clin Oncol, 25, pp.548~554 (2007)
- John GM, "Complementary and alternative medicine use among US cancer survivors", J Cancer Surviv, 10, pp.850~864 (2016)
- Tascilar M, "Complementary and alternative medicine during cancer treatment : beyond innocence", Oncologist, 11, pp.732~741 (2006)
- "Traditional, complementary and integrative medicine" (2019)[URL]
- "The use of complementary and alternative medicine in the United States" (2008)[URL]
- Meijerman I, "Herb-drug interactions in oncology : focus on mechanisms of induction", Oncologist, 11, pp.742~752 (2006)
- Mohd Mujar NM, "Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia", PLoS One, 12, pp.e0176394~ (2017)
- Nahin RL, "Expenditures on complementary health approaches: United States, 2012", Natl Health Stat Report, (95), pp.1~11 (2012)
- Bauml JM, "Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey", Cancer, 121, pp.2431~2438 (2015)
- Barrett B, "Themes of holism, empowerment, access, and legitimacy define complementary, alternative, and integrative medicine in relation to conventional biomedicine", J Altern Complement Med, 9, pp.937~947 (2003)
- Institute of Medicine, Committee on the Use of Complementary and Alternative Medicine by the American Public, "Complementary and alternative medicine in the United States", pp.34~64 (2005), National Academies Press
- Eardley S, "CAM use in Europe: the patients’ perspective. Part I: a systematic literature review of CAM prevalence in the EU" (2012), University of Southampton
- Alostad AH, "International comparison of five herbal medicine registration systems to inform regulation development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain", Pharmaceut Med, 32, pp.39~49 (2018)
- Job KM, "Herbal medicines: challenges in the modern world. Part 4. Canada and United States", Expert Rev Clin Pharmacol, 9, pp.1597~1609 (2016)
- Mehta DH, "Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions", J Altern Complement Med, 14, pp.1263~1269 (2008)
- Tarn DM, "A cross-sectional study of provider and patient characteristics associated with outpatient disclosures of dietary supplement use", Patient Educ Couns, 98, pp.830~836 (2015)
- Kennedy J, "Patient disclosure about herb and supplement use among adults in the US", Evid Based Complement Alternat Med, 5, pp.451~456 (2008)
- Farooqui M, "Complementary and alternative medicines(CAM)disclosure to the health care providers : a qualitative insight from Malaysian cancer patients", Complement Ther Clin Pract, 18, pp.252~256 (2012)
- Ernst E, "The role of complementary and alternative medicine", BMJ, 321, pp.1133~1135 (2000)
- Corbin Winslow L, "Physicians want education about complementary and alternative medicine to enhance communication with their patients", Arch Intern Med, 162, pp.1176~1181 (2002)
- Evans M, "Decisions to use complementary and alternative medicine(CAM)by male cancer patients : information-seeking roles and types of evidence used", BMC Complement Altern Med, 7, pp.25~ (2007)
- Latte-Naor S, "Influence of family on expected benefits of complementary and alternative medicine(CAM)in cancer patients", Support Care Cancer, 26, pp.2063~2069 (2018)